Research Progress of Chinese Medicine for Promoting Blood Circulation and Removing Blood Stasis in the Prevention and Treatment of Coronary Microvascular Dysfunction after Percutaneous Coronary Intervention
Traditional Chinese Medicine · 2026 · 15 (08) · 323-331
DOI: 10.12677/tcm.2026.158442 ↗Kurz gefasst
Fachartikel in der Zeitschrift Traditional Chinese Medicine, 2026. Verfasst von 思妤 董. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
冠状动脉微循环障碍(coronary microvascular dysfunction, CMD)作为冠心病不完全血运重建(incomplete revascularization, IR)术后发生心肌缺血的关键诱发因素,会直接关联到皮冠状动脉介入治疗在较长时间之后的预后情况,此病症的病理机制呈现出复杂的特性,运用西医的单一靶向治疗手段所获得的治疗效果并不理想。在中医领域,此病被归到“络脉瘀阻”这一范畴,具有多靶点干预优势特点的活血化瘀类中药,在改善IR术后患者发生心血管微血管疾病(CMD)上有较为明显的作用,基于对相关研究的总结,活血化瘀类药物能够通过抑制血小板聚集、保护血管内皮细胞、减轻炎症与氧化应激反应、调节血管平滑肌细胞功能以及推动新生血管生成等多种机制,对冠状动脉微循环产生积极的改善效果,像以通心络胶囊、麝香保心丸为代表的活血化瘀类中成药,在临床实践中已有初步证据显示出潜在的治疗价值,但其仍需要高质量的大样本随机对照试验来进一步验证其有效性和安全性。Coronary microvascular dysfunction (CMD) is a key triggering factor for myocardial ischemia following incomplete revascularization (IR) in patients with coronary artery disease, directly influencing long-term outcomes after percutaneous coronary intervention. The pathophysiological mechanisms of this condition are complex, and conventional single-target Western medical treatments have proven insufficiently effective. In traditional Chinese medicine (TCM), CMD falls under the category of “collateral stasis”, and blood-activating and stasis-resolving herbal medicines—known for their multi-target intervention advantages—have demonstrated notable efficacy in improving CMD after IR. Based on a summary of relevant research, these TCM drugs exert beneficial effects on coronary microcirculation through multiple mechanisms, including inhibition of platelet aggregation, protection of vascular endothelial cells, reduction of inflammation and oxidative stress, modulation of vascular smooth muscle cell function, and promotion of neovascularization. Formulations such as Tongxinluo Capsules and Shexiang Baoxin Pills have shown preliminary clinical evidence of potential therapeutic value; however, further high-quality, large-scale randomized controlled trials are needed to validate their effectiveness and safety.
Zitieren
APA
董, 思. (2026). Research Progress of Chinese Medicine for Promoting Blood Circulation and Removing Blood Stasis in the Prevention and Treatment of Coronary Microvascular Dysfunction after Percutaneous Coronary Intervention. Traditional Chinese Medicine, 15(08), 323-331. https://doi.org/10.12677/tcm.2026.158442
Vancouver
董 思. Research Progress of Chinese Medicine for Promoting Blood Circulation and Removing Blood Stasis in the Prevention and Treatment of Coronary Microvascular Dysfunction after Percutaneous Coronary Intervention. Traditional Chinese Medicine. 2026;15(08):323-331. doi:10.12677/tcm.2026.158442
BibTeX
@article{2026,
author = {董, 思妤},
title = {Research Progress of Chinese Medicine for Promoting Blood Circulation and Removing Blood Stasis in the Prevention and Treatment of Coronary Microvascular Dysfunction after Percutaneous Coronary Intervention},
journal = {Traditional Chinese Medicine},
year = {2026},
volume = {15},
number = {08},
pages = {323--331},
doi = {10.12677/tcm.2026.158442}
}
EUVIMED